NiSource Announces First Quarter Results
Reaffirming 2025 non-GAAP adjusted EPS guidance Reaffirming expected annual 6%-8% 2025-2029 non-GAAP adjusted EPS growth MERRILLVILLE, Ind.–(BUSINESS WIRE)–NiSource... Read more.
Trane Technologies to Present at the Wolfe Research Global Transportation and Industrials Conference
SWORDS, Ireland–(BUSINESS WIRE)–Trane Technologies plc (NYSE: TT) a global climate innovator, today announced that company leadership will participate... Read more.
Marea Therapeutics Presents Positive Data from Phase 2a Clinical Trial of MAR001, Being Developed for Cardiovascular Disease, in Late-Breaking Oral Session at the 93rd EAS Congress
MAR001, a first-in-class monoclonal antibody targeting ANGPTL4, demonstrated approximately 53% placebo-adjusted mean reduction in remnant cholesterol and placebo-adjusted... Read more.
The GEO Group Reports First Quarter 2025 Results
BOCA RATON, Fla.–(BUSINESS WIRE)–The GEO Group, Inc. (NYSE: GEO) (“GEO”), a leading provider of contracted support services for secure facilities,... Read more.
Improve Your Accounting Practice with Canopy Certifications
New Canopy University Offers Customer Certification and Learning Program SALT LAKE CITY–(BUSINESS WIRE)–#accounting—Canopy, the leading practice... Read more.
Owens Corning Delivers Strong Revenue and Margin Performance from Continuing Operations in the First Quarter
TOLEDO, Ohio–(BUSINESS WIRE)–Owens Corning (NYSE: OC), a building products leader, today reported first-quarter 2025 results. Reported Net Sales from... Read more.
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance
Delivered high-single-digit revenue growth, double-digit organic revenue growth, and continued operating margin expansion Raised full-year 2025 revenue guidance;... Read more.
WST INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that West Pharmaceutical Services, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO–(BUSINESS WIRE)–The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of West Pharmaceutical Services,... Read more.
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy
Top-line results at 12 months of treatment show meaningful improvement over time: Overall responder rate of 65% Overall reduction in median apnea-hypopnea index... Read more.
Discover Survey: Americans Seek to Improve Their Financial Lives Amid Uncertainty
Two-thirds of Americans are experiencing moderate to high financial stress, and half aren’t financially prepared for the unexpected RIVERWOODS, Ill.–(BUSINESS... Read more.